Babczyńska, M. et al. 2025. Comparative Effectiveness of Risankizumab vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes after Inadequate Response to Prior Therapy. Quality in Sport. 41, (May 2025), 59986. DOI:https://doi.org/10.12775/QS.2025.41.59986.